About
Professional Summary
Mr. (Dr.) Bikash R Jena has over 8.7 years of research experience in the field of pharmaceutical Analysis, especially development and validation of some selected anticancer molecules employing Analytical QbD approach, Bioanalytical development. Currently, he is working as the Research Scholar at KL Deemed University, (UGC, NAAC A ++ accredited) and working at Centurion University, BBSR, Odisha.
Education
Academic Background-
Ph.D. Koneru Lakshmaiah Education Foundation, India Pharmaceutical Analysis | Completed: 2021
-
M. Pharm. Biju Patnaik University of Technology, India Analytical & Inorganic Chemistry | Completed: 2012
-
B. Pharm. Biju Patnaik University of Technology, India Pharmaceutical Sciences | Completed: 2010
Publications (21)
Selected Scholarly Contributions
Response Surface Methodology-driven RP-HPLC-PDA Approach to Analytical Method Development, Validation, and Quantitation of Ixazomib
in its Pharmaceutical Formulations
2026
Revolutionizing Drug Discovery: Modern Advancements in Quality by Design, PAT Tools, and Green Chemistry
2026
Chitosan-functionalized PLGA Nanoparticles: Exploring Recent Patents,
Advanced Strategies for Controlled and Targeted Anticancer Therapy
2026
Integration of quality by design with artificial intelligence/machine learning technologies in pharmaceutical manufacturing: A comprehensive review
2026
Comprehensive Review on AQbD-Enabled Latest Advancements of Bioanalysis Using Hyphenated Techniques in Drug Product Development
2026
Exploring application & recent advances of response surface methodology driven approach in drug design and nanotechnology
2025
Quality By Design Enabled Carvedilol Self-Nanoemulsifying Drug Delivery System: In-Vitro and In-Vivo Characterization for Improved Management of Hypertension
2025
Envisioning Clinical Management of Breast Cancer: a Comprehensive Review
2025
Biodegradable Polymer-based Nanoparticles: A Breakthrough in Oral Protein Drug Delivery
2025
Genotoxic Impurities in Critical Analysis of Product Development: Recent
Advancements, Patents, and Current Challenges
2024
Current Advancements on Oral Protein and Peptide Drug Delivery Approaches to Bioavailability: Extensive Review on Patents
2024
Modern Advancements, Patents and Applications of Futuristic
Nanozymes: A Comprehensive Review
2023
QbD-based Formulation Optimization and Characterization of Polymeric Nanoparticles of Cinacalcet Hydrochloride with Improved Biopharmaceutical Attributes
2021
AQbD Driven Development of an RP-HPLC Method for the Quantitation of Abiraterone Acetate for its Pharmaceutical Formulations in the Presence of Degradants
2021
Applications of QbD-based software’s in analytical research and development.
Bikash Ranjan Jena
2021
A trimethoxy flavonoid isolated from stem extract of Tabebuia chrysantha suppresses angiogenesis in angiosarcoma.
Bikash Ranjan Jena
2020
Stem extract of Tabebuia chrysantha induces apoptosis by targeting sEGFR in Ehrlich Ascites Carcinoma.
Bikash Ranjan Jena
2019
Formulation development, statistical optimization and characterization of the self-microemulsifying drug delivery system (SMEDDS) of Irbesartan.
Bikash Ranjan Jena
2019
Mucoadhesive multiparticulate drug delivery systems: an extensiveReview of patents.
Bikash Ranjan Jena
2019
2019
Overexpressed CYP450 mediated apoptosis evaluates cytotoxicity and teratotoxicity of cucumis callosus.
Bikash Ranjan Jena
2018